Everus (NYSE:ECG – Get Free Report) announced its quarterly earnings results on Tuesday. The company reported $0.67 EPS for the quarter, missing analysts’ consensus estimates of $0.73 by ($0.06), Zacks reports. Everus updated its FY 2025 guidance to EPS.
Everus Stock Performance
ECG stock opened at $68.32 on Wednesday. The company has a current ratio of 1.58, a quick ratio of 1.50 and a debt-to-equity ratio of 0.47. The firm’s fifty day moving average price is $68.95. Everus has a one year low of $40.05 and a one year high of $77.93.
Analyst Upgrades and Downgrades
Several analysts have issued reports on ECG shares. DA Davidson assumed coverage on shares of Everus in a research note on Monday, November 4th. They issued a “neutral” rating and a $55.00 price objective for the company. Wolfe Research began coverage on Everus in a research report on Tuesday, December 3rd. They set a “peer perform” rating on the stock. Stifel Nicolaus increased their target price on shares of Everus from $78.00 to $85.00 and gave the company a “buy” rating in a research report on Friday, January 24th. Finally, Oppenheimer boosted their price target on Everus from $70.00 to $80.00 and gave the stock an “outperform” rating in a research note on Tuesday, January 7th.
Everus Company Profile
Everus Construction Group is providing a full spectrum of construction services through its electrical and mechanical and transmission and distribution specialty contracting services principally in United States. Its specialty contracting services are provided to utility, transportation, commercial, industrial, institutional, renewable and other customers.
Featured Articles
- Five stocks we like better than Everus
- What is a SEC Filing?
- Will the Tariff Bump Lead to a Steel Trap?
- What is the Australian Securities Exchange (ASX)
- Rebuilding Stronger: 3 Stocks Driving Infrastructure Recovery
- How is Compound Interest Calculated?
- GLP-1 Alternatives: 2 Stocks Benefiting From Weight Loss Trends
Receive News & Ratings for Everus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Everus and related companies with MarketBeat.com's FREE daily email newsletter.